Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

21.25
-0.4300-1.98%
Pre-market: 21.490.2415+1.14%04:00 EDT
Volume:756.58K
Turnover:16.14M
Market Cap:1.22B
PE:-10.91
High:21.68
Open:21.66
Low:21.04
Close:21.68
52wk High:42.43
52wk Low:16.67
Shares:57.27M
Float Shares:54.47M
Volume Ratio:0.83
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9478
EPS(LYR):-1.7207
ROE:-30.24%
ROA:-14.39%
PB:3.58
PE(LYR):-12.35

Loading ...

PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate

Benzinga Earnings
·
Aug 05

Procept Biorobotics Q2 Revenue USD 94.498 Million Vs. IBES Estimate USD 92.9 Million

Reuters
·
Aug 05

Procept Biorobotics Outlook FY Gross Margin 65%

THOMSON REUTERS
·
Aug 05

Procept Biorobotics Outlook FY Revenue USD 390-410 Million

THOMSON REUTERS
·
Aug 05

Procept Biorobotics Corp - Expects Fy2026 U.S. Procedure Volume of 54,000-56,000, up 25%-29%

THOMSON REUTERS
·
Aug 05

PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 05

PROCEPT BioRobotics Lawsuit Puts PRCT Investor Losses in Focus After Alleged Handpiece Demand Disclosures

TIPRANKS
·
Jul 31

Earning Preview: PROCEPT BioRobotics Q2 revenue is expected to increase by 21.59%, and institutional views are bullish

Earnings Agent
·
Jul 29

Medical Robotics Firm PROCEPT BioRobotics Faces Class Action Over Hidden Discount Scheme

Deep News
·
Jul 29

Medical Robotics Company PROCEPT BioRobotics Confronts Securities Fraud Lawsuit Over Discount Disclosure Issues

Deep News
·
Jul 29

Procept BioRobotics Coverage Assumed by UBS at Neutral vs Previous Rating of Buy

Dow Jones
·
Jul 29

UBS Downgrades PROCEPT BioRobotics to Neutral From Buy, Cuts Price Target to $20 From $30

MT Newswires Live
·
Jul 28

Shareholder Action Against Surgical Robotics Firm Over Alleged Deceptive Sales Practices

Deep News
·
Jul 27

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jul 16

Mobia Medical Names Reza Zadno to Board as Independent Director

Reuters
·
Jul 16

Mobia Medical Appoints Reza Zadno, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
Jul 16

Procept Biorobotics to Report Q2 Results After Market Close, Host Conference Call

Reuters
·
Jul 15

PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026

GlobeNewswire
·
Jul 15

Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jul 07

Procept Biorobotics Cut to Hold from Buy by Truist Securities

Dow Jones
·
Jul 06